Palantir Stock Faces Scrutiny Amid Hype and Caution
Palantir's stock fell 2% after Citron Research expressed caution about its valuation, comparing it unfavorably to OpenAI and highlighting insider selling concerns, amid broader worries about AI market bubbles and competitive pressures.